Jean Carper: Looking for Alzheimer’s Answers in All the Wrong Places

The news about Alzheimer’s is dismal. A new Eli Lilly drug to treat Alzheimer’s has failed big-time. After investing hundreds of millions of dollars in the drug, Semagacestat, the company announced it made patients worse.

Story continues here ➤